214 related articles for article (PubMed ID: 30072699)
1. Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family.
Kumar A; Bandapalli OR; Paramasivam N; Giangiobbe S; Diquigiovanni C; Bonora E; Eils R; Schlesner M; Hemminki K; Försti A
Sci Rep; 2018 Aug; 8(1):11635. PubMed ID: 30072699
[TBL] [Abstract][Full Text] [Related]
2. Whole Genome Sequencing Prioritizes
Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
[TBL] [Abstract][Full Text] [Related]
3. Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways.
Srivastava A; Kumar A; Giangiobbe S; Bonora E; Hemminki K; Försti A; Bandapalli OR
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614935
[TBL] [Abstract][Full Text] [Related]
4. Identification of Rare Variants Predisposing to Thyroid Cancer.
Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
[No Abstract] [Full Text] [Related]
5. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
[TBL] [Abstract][Full Text] [Related]
6. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
[TBL] [Abstract][Full Text] [Related]
7. Germ-line mutations in
Zhao Y; Yu T; Sun J; Wang F; Cheng C; He S; Chen L; Xie D; Fu L; Guan X; Yan A; Li Y; Miao G; Zhu X
Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326253
[TBL] [Abstract][Full Text] [Related]
8. A Germline
Zhao Y; Yu T; Chen L; Xie D; Wang F; Fu L; Cheng C; Li Y; Zhu X; Miao G
Thyroid; 2020 Jun; 30(6):924-930. PubMed ID: 32041497
[TBL] [Abstract][Full Text] [Related]
9. Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.
Srivastava A; Giangiobbe S; Kumar A; Paramasivam N; Dymerska D; Behnisch W; Witzens-Harig M; Lubinski J; Hemminki K; Försti A; Bandapalli OR
Front Bioeng Biotechnol; 2020; 8():179. PubMed ID: 32211398
[TBL] [Abstract][Full Text] [Related]
10. HABP2 G534E Variant in Papillary Thyroid Carcinoma.
Tomsic J; Fultz R; Liyanarachchi S; He H; Senter L; de la Chapelle A
PLoS One; 2016; 11(1):e0146315. PubMed ID: 26745718
[TBL] [Abstract][Full Text] [Related]
11. Identification of
Marques IJ; Gomes I; Pojo M; Pires C; Moura MM; Cabrera R; Santos C; van IJcken WFJ; Teixeira MR; Ramalho JS; Leite V; Cavaco BM
Thyroid; 2021 Sep; 31(9):1366-1375. PubMed ID: 33906393
[No Abstract] [Full Text] [Related]
12. Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in
Nieminen TT; Walker CJ; Olkinuora A; Genutis LK; O'Malley M; Wakely PE; LaGuardia L; Koskenvuo L; Arola J; Lepistö AH; Brock P; Yilmaz AS; Eisfeld AK; Church JM; Peltomäki P; de la Chapelle A
Thyroid; 2020 Mar; 30(3):380-388. PubMed ID: 32024448
[No Abstract] [Full Text] [Related]
13. A Truncating Germline Mutation of
He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
[No Abstract] [Full Text] [Related]
14. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
[TBL] [Abstract][Full Text] [Related]
15. Exploration of BRAFV600E as a diagnostic adjuvant in the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Johnson DN; Sadow PM
Hum Pathol; 2018 Dec; 82():32-38. PubMed ID: 30146440
[TBL] [Abstract][Full Text] [Related]
16. Pedigree based DNA sequencing pipeline for germline genomes of cancer families.
Försti A; Kumar A; Paramasivam N; Schlesner M; Catalano C; Dymerska D; Lubinski J; Eils R; Hemminki K
Hered Cancer Clin Pract; 2016; 14():16. PubMed ID: 27508007
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of tumors meeting diagnostic criteria for the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Pool C; Walter V; Bann D; Goldenberg D; Broach J; Hennessy M; Cottrill E; Washburn E; Williams N; Crist H; Imamura Y; Warrick JI
Virchows Arch; 2019 Mar; 474(3):341-351. PubMed ID: 30645670
[TBL] [Abstract][Full Text] [Related]
18. The impact of NOS3 gene polymorphism on papillary thyroid cancer susceptibility in patients undergoing radioiodine therapy.
Cerqueira ARD; Fratelli CF; Duarte LCAC; Pereira ASR; Morais RM; Sobrinho AB; Silva CMS; Silva ICRD; Oliveira JR
Int J Biol Markers; 2020 Dec; 35(4):87-91. PubMed ID: 33208017
[TBL] [Abstract][Full Text] [Related]
19. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population.
de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC
Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015
[TBL] [Abstract][Full Text] [Related]
20. Germline Mutations in Familial Papillary Thyroid Cancer.
Sarquis M; Moraes DC; Bastos-Rodrigues L; Azevedo PG; Ramos AV; Reis FV; Dande PV; Paim I; Friedman E; De Marco L
Endocr Pathol; 2020 Mar; 31(1):14-20. PubMed ID: 32034658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]